[Association of hetacillin and dicloxacillin in 4:3 ratio. Pharmacological research, in-vitro activity and clinical use].
D000293:Adolescent; D000328:Adult; D000368:Aged; D001419:Bacteria / Q000187:drug effects*; D001424:Bacterial Infections / Q000188:drug therapy*; D002648:Child; D002764:Cholecystitis / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D004009:Dicloxacillin / Q000494:pharmacology / Q000627:therapeutic use*; D004338:Drug Combinations; D004357:Drug Synergism; D005260:Female; D006801:Humans; D007169:Impetigo / Q000188:drug therapy; D008297:Male; D008581:Meningitis / Q000188:drug therapy*; D008826:Microbial Sensitivity Tests; D008875:Middle Aged; D010406:Penicillins / Q000494:pharmacology / Q000627:therapeutic use*; D012141:Respiratory Tract Infections / Q000188:drug therapy*; D012541:Scarlet Fever / Q000188:drug therapy
D004338:Drug Combinations; D010406:Penicillins; D004009:Dicloxacillin
Associazione etacillina-dicloxacillina in rapporto 4:3. Ricerca farmacologica, attività in vitro e applicazione clinica.